Drug delivery systems in the treatment of African trypanosomiasis infections
Authors:
- 30 March 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 8 (6) , 735-747
Abstract
(2011). Drug delivery systems in the treatment of African trypanosomiasis infections. Expert Opinion on Drug Delivery: Vol. 8, No. 6, pp. 735-747. doi: 10.1517/17425247.2011.574122Keywords
This publication has 97 references indexed in Scilit:
- Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping SicknessPLOS Neglected Tropical Diseases, 2010
- NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping SicknessPLOS Neglected Tropical Diseases, 2010
- Human African trypanosomiasisThe Lancet, 2010
- Human African trypanosomiasis: pharmacological re‐engagement with a neglected diseaseBritish Journal of Pharmacology, 2007
- Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆Advanced Drug Delivery Reviews, 2007
- Chemotherapy of Human African TrypanosomiasisCurrent Pharmaceutical Design, 2002
- Problems for the chemotherapy of human African trypanosomiasisCurrent Opinion in Infectious Diseases, 2000
- Pharmacology of existing drugs for animal trypanosomiasisActa Tropica, 1993
- Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathiesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Topological analysis of antigenic determinants on a variant surface glycoprotein of Trypanosoma bruceiMolecular and Biochemical Parasitology, 1984